The current landscape of factor XI inhibitors
Anticoagulant therapy has always been tightly connected with bleeding risk, as two sides of the same coin. New insights in thrombosis and hemostasis prompted the development of intrinsic pathway inhibitors that promise to uncouple thrombosis and hemostasis. Treating and preventing thrombotic complic...
| Published in: | Thrombosis Update |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2666572724000130 |
